Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adverse drug reaction
amphetamines
analgesic
anesthesia, general
anesthesia, local
antibiotics
antibiotics, neurologic complications with
anticholinesterase
anticonvulsants
anticonvulsants, untoward effects of
antidepressant
baclofen
beta adrenergic blocker
camphor
capsaicin
chlorambucil
clonidine
cluster headache
cocaine
contrast agents, neurotoxicity of
cyclosporine
desipramine
dilantin
drug induced neurologic disorders
ephedrine
epidemiology of neurology
ergonovine
folic acid
headache, treatment of
hyperbaric oxygen
hyperbaric treatment
intranasal medication
lidocaine
lidocaine, intranasal
lidocaine, intravenous
mexiletine
mononeuropathy
nalidixic acid
narcotic analgesics
neuropathy
neuropathy, etiologies of
neuropathy, painful
neuropathy, peripheral, treatment
nortriptyline
opiate
pain
pain, management of chronic
pain, neuropathic
penicillin
phencyclidine poisoning
phenobarbital
phenylpropanolamine
physostigmine
post herpetic neuralgia
propranolol
quality of life
review article
seizure
seizure, drug-induced
sympathomimetic drugs
treatment of neurologic disorder
tricyclic antidepressant
vitamin K
Showing articles 700 to 750 of 1396 << Previous Next >>

Brown-Sequard Syndrome After Esophageal Sclerotherapy and Crack Cocaine Abuse
Neurol 58:1129-1130, Mueller,D. &Gilden,D.H., 2002

Thrombolysis in Patients with Acute Stroke Caused by Cervical Artery Dissection
Arch Neurol 59:549-553, Arnold,M.,et al, 2002

Alteplase for Stroke: Money and Optimistic Claims Buttress the "Brain Attack" Campaign
BMJ 324:723-729, Lenzer,J., 2002

Cranial MR Findings in Chronic Toluene Abuse by Inhalation
AJNR 23:1173-1179,1072, Aydin, K.,et al, 2002

Nanging
Lancet 360:384, Ng, J. &Frith, R., 2002

Clinical and Vascular Outcome in Internal Carotid Artery Versus Middle Cerebral Artery Occlusions After Intravenous Tissue Plasminogen Activator
Stroke 33:2066-2071, Linfante, I.,et al, 2002

Comparison of Admission Perfusion Computed Tomography and Qualitative Diffusion- and Perfusion-Weighted Magnetic Resonance Imaging in Acute Stroke Patients
Stroke 33:2025-2031, Wintermark,M.,et al, 2002

Predictors of Hemorrhagic Transformation After Intravenous Recombinant Tissue Plasminogen Activator
Stroke 33:2047-2052, Selim,M.,et al, 2002

Intra-Arterial Thrombolysis in 100 Patients With Acute Stroke Due to Middle Cerebral Artery Occlusion
Stroke 33:1828-1833, Arnold,M.,et al, 2002

Response of Intra-Arterial and Combined Intravenous and Intra-Arterial Thrombolytic Therapy in Patients with Distal Internal Carotid Artery Occlusion
Stroke 33:1821-1826,1827, Zaidat,O.O,et al, 2002

Worsening of Multifocal Motor Neuropathy During Pregnancy
Neurol 59:139-141, Chaudhry,V.,et al, 2002

Signs of Acute Stroke Seen on Fluid-Attenuated Inversion Recovery MR Imaging
AJR 179:237-243, Makkat,S.,et al, 2002

Orbital Infarction After Cocaine Use
Neurol 59:642, Van Stavern,G.P. &Gorman,M., 2002

Admission Glucose Level and Clinical Outcomes in the NINDS rt-PA Stroke Trial
Neurol 59:669-674, Bruno,A.,et al, 2002

CADASIL Mimicking Primary Angiitis of the Central Nervous System
Arch Neurol 59:1480-1483, Engelter,S.T.,et al, 2002

Prognosis of Central Retinal Artery Occlusion:Local Intraarterial Fibrinolysis versus Conservative Treatment
AJNR 23:1301-1307, Schmidt,D.P.,et al, 2002

Baseline Blood Pressure but Not Early Computed Tomography Changes Predicts Major Hemorrhage After Streptokinase in Acute Ischemic Stroke
Stroke 33:22236-2242, Gilligan,A.K.,et al, 2002

Arterial Reocclusion in Stroke Patients Treated with Intravenous Tissue Plasminogen Activator
Neurol 59:862-867, Alexandrov,A.V. &Grotta,J.C., 2002

Complete Recovery After Early Intraarterial Recombinant Tissue Plasminogen Activator Thrombolysis of Carotid T Occlusion
AJNR 23:1596-1599, Rabinstein,A.A., et al, 2002

Safety of Tissue Plasminogen Activator for Acute Stroke in Menstruating Women
Stroke 33;2506-2508, Wein,T.H.,et al, 2002

Thrombolysis for Acute Stroke in Routine Clinical Practice
Arch Int Med 162:1994-2001, Bravata,D.M.,et al, 2002

Dose-Related Neurocognitive Effects of Marijuana Use
Neurol 59:1337-1343,1295, Bolla,K.I.,et al, 2002

Late Secondary Ischemic Injury in Patients Receiving Intraarterial Thrombolysis
Ann Neurol 52:698-703,695, Kidwell,C.S.,et al, 2002

Analysis of the Safety and Efficacy of Intra-Arterial Thrombolytic Therapy in Ischemic Stroke
Stroke 33:2866-2870, Lisboa,R.C.,et al, 2002

Direct Percutaneous Transluminal Angioplasty for Acute Middle Cerebral Artery Trunk Occlusion
Stroke 33:2872-2876, Nakano,S.,et al, 2002

Prognostic Accuracy of Cerebral Blood Flow Measurement by Perfusion Computed Tomography, at the Time of Emergency Room Admission, in Acute Stroke Patients
Ann Neurol 51:417-432,415, Wintermark,M.,et al, 2002

Computed Tomographic Findings in Patients Undergoing Intra-arterial Thrombolysis for Acute Ischemic Stroke Due to Middle Cerebral Artery Occlusion
Stroke 33:1557-1567, Roberts,H.C.,et al, 2002

Thrombolysis-Related Hemorrhagic Infarction
Stroke 33:1551-1556,1446, Molina,C.A.,et al, 2002

Intraarterial Thrombolysis: Ready for Prime Time?
AJNR 22:55-58, Executive Committee of the ASITN, 2001

Protocol Violations in Community-Based rTPA Stroke Treatment Are Associated with Symptomatic Intracerebral Hemorrhage
Stroke 32:12-16, Lopez-Yunez,A.M.,et al, 2001

Positive Response to Immunommodulatory Therapy in an Adult Patient with Rasmussen's Encephalitis
Neurol 56:248-250, Villani,F.,et al, 2001

Risk Factors for Sever Hemorrhagic Transformation in Ischemic Stroke Patients Treated with Recombinant Tissue Plasminogen Activator
Stroke 32:438-441, Larrue,V.,et al, 2001

Combined Intraarterial/Intravenous Thrombolysis for Acute Ischemic Stroke
AJNR 22:352-358, Keris,V.,et al, 2001

A Controlled Study of Intravenous Immunoglobulin Combined with Prednisone in the Treatment of IBM
Neurol 56:323-327, Dalakas,M.C.,et al, 2001

A Case of Immunotherapy-Responsive Eastern Equine Encephalitis with Diffusion-Weighted Imaging
Neurol 56:420-421, Golomb,M.R.,et al, 2001

Deterioration Following Improvement with tPA Therapy: Carotid Thrombosis and Reocclusion
Neurol 56:568-570, Burgin,W.S. &Alexandrov,A.V., 2001

Randomized Controlled Trial of IVIg in Untreated Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Neurol 56:445-449, Mendell,J.R.,et al, 2001

Clinical Deterioration Following Improvement in the NINDS rt-PA Stroke Trial
Stroke 32:661-668, Grotta,J.C.,et al, 2001

Rapid Initiation of Gabapentin, A Randomized, Controlled Trial
Neurol 56:743-748, Fisher,R.S.,et al, 2001

Epilepsy
NEJM 344:1145-1151, Browne,T.R. & Holmes,G.L., 2001

Spontaneous Intracerebral Hemorrhage
NEJM 344:1450-1460, Qureshi,A.I.,et al, 2001

Most Commonly Asked Questions About Intra-arterial Thrombolysis
The Neurologist 7:127-131, Wechsler,L.R., 2001

Utilization of Intravenous Tissue-Type Plasminogen Activator for Ischemic Stroke at Academic Medical Centers
Stroke 32:1061-1068, Claiborne Johnston,S.,et al, 2001

Intravenous tPA for Ischemic Stroke Team Performance Over Time, Safety, and Efficacy in a Single-Center, 2-Year Experience
Stroke 32:1074-1078, Koennecke,H.,et al, 2001

Benefits of Perfusion MR Imaging Relative to Diffusion MR Imaging in the Diagnosis and Treatment of Hyperacute Stroke
AJNR 22:915-921,806, Sunshine,J.L.,et al, 2001

Community Use of Intravenous Tissue Plasminogen Activator for Acute Stroke
Stroke 32:861-865, Katzan,I.L.,et al, 2001

Cocaine-Induced Persistent Dyskinesias
Neurol 56:964-965, Weiner,W.J.,et al, 2001

Memory Impairment in Abstinent MDMA ("Ecstasy") Users: A Longitudinal Investigation
Neurol 56:966-969, Zakzanis,K.K. & Young,D.A., 2001

Why Are Stroke Patients Excluded from TPA Therapy?
Neurol 56:1015-1020, Barber,P.A.,et al, 2001

Playing the Odds in Clinical Decision Making: Lessons from Berry Aneurysms Undetected by Magnetic Resonance Angioography
BMJ 322:1347-1349, Johnson,M.R.,et al, 2001



Showing articles 700 to 750 of 1396 << Previous Next >>